BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23183531)

  • 1. Mouse KLF11 regulates hepatic lipid metabolism.
    Zhang H; Chen Q; Yang M; Zhu B; Cui Y; Xue Y; Gong N; Cui A; Wang M; Shen L; Zhang S; Fang F; Chang Y
    J Hepatol; 2013 Apr; 58(4):763-70. PubMed ID: 23183531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα.
    Guo Y; Yu J; Deng J; Liu B; Xiao Y; Li K; Xiao F; Yuan F; Liu Y; Chen S; Guo F
    Diabetes; 2016 Aug; 65(8):2151-63. PubMed ID: 27207553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF10 transcription factor regulates hepatic glucose metabolism in mice.
    Yang X; Chen Q; Sun L; Zhang H; Yao L; Cui X; Gao Y; Fang F; Chang Y
    Diabetologia; 2017 Dec; 60(12):2443-2452. PubMed ID: 28836014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of KLF11 in hepatic glucose metabolism in mice via suppressing of PEPCK-C expression.
    Zhang H; Chen Q; Jiao T; Cui A; Sun X; Fang W; Xie L; Liu Y; Fang F; Chang Y
    PLoS One; 2014; 9(2):e89552. PubMed ID: 24586865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.
    Wang L; Tong X; Gu F; Zhang L; Chen W; Cheng X; Xie L; Chang Y; Zhang H
    J Biol Chem; 2017 Dec; 292(52):21631-21642. PubMed ID: 29123026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of loganin, iridoid glycoside from Corni Fructus, on hepatic and renal glucolipotoxicity and inflammation in type 2 diabetic db/db mice.
    Yamabe N; Noh JS; Park CH; Kang KS; Shibahara N; Tanaka T; Yokozawa T
    Eur J Pharmacol; 2010 Dec; 648(1-3):179-87. PubMed ID: 20826139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bixin activates PPARα and improves obesity-induced abnormalities of carbohydrate and lipid metabolism in mice.
    Goto T; Takahashi N; Kato S; Kim YI; Kusudo T; Taimatsu A; Egawa K; Kang MS; Hiramatsu T; Sakamoto T; Uemura T; Hirai S; Kobayashi M; Horio F; Kawada T
    J Agric Food Chem; 2012 Dec; 60(48):11952-8. PubMed ID: 23145898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin regulatory element-binding (PREB) protein regulates hepatic glucose homeostasis.
    Park JM; Kim MY; Kim TH; Min DK; Yang GE; Ahn YH
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2097-2107. PubMed ID: 29601978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T; Tsunoda M; Mochizuki T; Murakami K
    Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
    Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
    Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance.
    Sun N; Shen C; Zhang L; Wu X; Yu Y; Yang X; Yang C; Zhong C; Gao Z; Miao W; Yang Z; Gao W; Hu L; Williams K; Liu C; Chang Y; Gao Y
    Gut; 2021 Nov; 70(11):2183-2195. PubMed ID: 33257471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
    Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Characterization of Mice Carrying Homozygous Deletion of KLF11, a Gene in Which Mutations Cause Human Neonatal and MODY VII Diabetes.
    Mathison A; Escande C; Calvo E; Seo S; White T; Salmonson A; Faubion WA; Buttar N; Iovanna J; Lomberk G; Chini EN; Urrutia R
    Endocrinology; 2015 Oct; 156(10):3581-95. PubMed ID: 26248217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice.
    Qiao L; MacLean PS; You H; Schaack J; Shao J
    Endocrinology; 2006 Jun; 147(6):3060-9. PubMed ID: 16543372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.